SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001731122-23-000348
Filing Date
2023-03-13
Accepted
2023-03-10 18:32:56
Documents
12
Period of Report
2023-03-10
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 FORM 8-K e4486_8-k.htm   iXBRL 8-K 23904
  Complete submission text file 0001731122-23-000348.txt   196123

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE avxl-20230310.xsd EX-101.SCH 3221
3 XBRL LABEL FILE avxl-20230310_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE avxl-20230310_pre.xml EX-101.PRE 22355
6 EXTRACTED XBRL INSTANCE DOCUMENT e4486_8-k_htm.xml XML 3607
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

IRS No.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-37606 | Film No.: 23725182
SIC: 2836 Biological Products, (No Diagnostic Substances)